Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001643441-26-000002
Filing Date
2026-05-18
Accepted
2026-05-18 16:52:48
Documents
1
Period of Report
2026-05-18

Document Format Files

Seq Description Document Type Size
1 form4-05182026_080544.html 4  
1 form4-05182026_080544.xml 4 28209
  Complete submission text file 0001643441-26-000002.txt   29740
Mailing Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065
Business Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Issuer) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SOLENO THERAPEUTICS, INC. 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065
Business Address
Yen Kristen (Reporting) CIK: 0001643441 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36593 | Film No.: 26994411